Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

VEGFR-2, CXCR-2 and PAR-1 germline polymorphisms as predictors of survival in pancreatic carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology - 1 May 2013

Uzunoglu F G, Kolbe J, Wikman H, Güngör C, Bohn B A, Nentwich M F, Reeh M, König A M, Bockhorn M, Kutup A, Mann O, Izbicki J R, Vashist Y K

Abstract excerpt

BACKGROUND: Hypoxic environment of pancreatic cancer (PC) implicates high vascular in-growth, which may be influenced by angiogenesis-related germline polymorphisms. Our purpose was to evaluate polymorphisms of vascular endothelial growth factor receptor 2 (VEGFR-2), CXC chemokine receptor 2 (CXCR-2), proteinase-activated receptor 1 (PAR-1) and endostatin (ES) as prognostic markers for disease-free (DFS) and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neovascularization, Pathologic

Share to Pancreatic Neoplasms

Share to Receptor, PAR-1

Share to Receptors, Interleukin-8B

Share to Survival

Share to Vascular Endothelial Growth Factor Receptor-2

Source

Identifiers

PMID: 23293110
DOI: 10.1093/annonc/mds634

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

VEGFR-2, CXCR-2 and PAR-1 germline polymorphisms as predictors of survival in pancreatic carcinoma.PMID 23293110Read ↗

C-X-C motif receptor 2, endostatin and proteinase-activated receptor 1 polymorphisms as prognostic factors in NSCLC.Semantic proximity Read ↗

Determination of VEGFR-2 (KDR) 604A>G Polymorphism in Pancreatic Disorders.Semantic proximity Read ↗

CXCR2 and RET single nucleotide polymorphisms in pancreatic cancer.Semantic proximity Read ↗

The protease activated receptor 1 gene variation IVSn -14 A>T is associated with distant metastasis and cancer specific survival in renal cell carcinoma.Semantic proximity Read ↗

Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms.Semantic proximity Read ↗

Genetic variants in the platelet-derived growth factor subunit B gene associated with pancreatic cancer risk.Semantic proximity Read ↗

Genetic variations in angiogenesis pathway genes associated with clinical outcome in localized gastric adenocarcinoma.Semantic proximity Read ↗

Genetic Variations in Angiogenesis Pathway Genes Predict Tumor Recurrence in Localized Adenocarcinoma of the EsophagusSemantic proximity Read ↗

Association of VEGFR1, VEGFR2 and VEGFR3 Polymorphisms with Esophageal Cancer Risk: A Case- Control StudySemantic proximity Read ↗

PDGFRα/β and VEGFR2 polymorphisms in colorectal cancer: incidence and implications in clinical outcome.Semantic proximity Read ↗

A single nucleotide polymorphism of the cholecystokinin-B receptor predicts risk for pancreatic cancer.Semantic proximity Read ↗

Pancreatic Cancer Epidermal Growth Factor Receptor (EGFR) Intron 1 Polymorphism Influences Postoperative Patient Survival and in vitro Erlotinib ResponseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.